The offspring of irradiated parents, are they stable?

Mutation Research
R Barber, Yuri E Dubrova

Abstract

Mutation induction in directly exposed cells is currently regarded as the main component of the genetic risk of ionising radiation for humans. However, recent studies showing that exposure to ionising radiation results in elevated mutation rates detectable in the non-irradiated progeny of exposed cells challenge the existing paradigm in radiation biology. This review describes some recent data on radiation-induced genomic instability in vitro and mainly focuses on the in vivo phenomenon of transgenerational instability, where elevated mutation rates are detected in the non-exposed offspring of irradiated parents. The possible mechanisms and implications of transgenerational instability are also discussed.

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·W M GenerosoS W Huff
Jan 1, 1976·Mutation Research·K G Lüning, A Eiche
Aug 1, 1988·Health Physics·D T Goodhead
Sep 1, 1993·Nature Genetics·Y E DubrovaA M Malashenko
Apr 1, 1997·Current Biology : CB·I RoemerJ Klose
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S ZhangB A Mock
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y E DubrovaA J Jeffreys
Jan 9, 1999·International Journal of Radiation Biology·E G Wright
Jan 9, 1999·International Journal of Radiation Biology·B I LordD Scott
Oct 20, 1999·Cellular and Molecular Life Sciences : CMLS·P Bois, A J Jeffreys
May 16, 2000·Nature·Y E DubrovaA J Jeffreys
Oct 18, 2001·Radiation Research·K P HoyesI D Morris
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Heather O Dickinson, Louise Parker
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ruth BarberYuri E Dubrova
Jun 25, 2002·International Journal of Radiation Biology·D J Brenner, R K Sachs
Jul 11, 2002·Mutation Research·William F MorganBrian Ponnaiya
Aug 27, 2002·Radiation Protection Dosimetry·K M PriseB D Michael
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lawrence A LoebJon P Anderson
Apr 26, 2003·Mutation Research·Carles Vilariño-GüellYuri E Dubrova
Oct 15, 2003·Oncogene·Yuri E Dubrova
Nov 25, 2003·Occupational and Environmental Medicine·P A McKinneyUNKNOWN UK Childhood Cancer Study Investigators

❮ Previous
Next ❯

Citations

May 7, 2009·Zygote : the Biology of Gametes and Early Embryos·Ming-Wen LiK C Kent Lloyd
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Colin D Glen, Yuri E Dubrova
Sep 5, 2008·Annual Review of Genomics and Human Genetics·Neil A Youngson, Emma Whitelaw
Jun 5, 2008·PloS One·Keith Baverstock, Mauno Rönkkö
Aug 19, 2007·Expert Opinion on Drug Metabolism & Toxicology·Timothy W Gant
Dec 26, 2009·Radiation and Environmental Biophysics·Jaroslaw DziegielewskiJanet E Baulch
Dec 28, 2010·Radiation Protection Dosimetry·S S SorokinaV N Peleshko
Jul 17, 2012·Mutation Research·Katriina HuumonenJukka Juutilainen
Jan 2, 2016·Seminars in Cancer Biology·Olga A MartinRoger F Martin
Mar 3, 2010·Mutation Research·Michelle B Norris, Richard N Winn
Jan 20, 2010·Mutation Research·Carmel Mothersill, Colin Seymour
Jan 24, 2008·Environmental and Molecular Mutagenesis·Richard N WinnMichelle B Norris
Jun 26, 2012·Environmental and Molecular Mutagenesis·Eugenia CordelliPaola Villani
Sep 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Igor KoturbashOlga Kovalchuk
Feb 28, 2006·Mutation Research·Mário Gomes-Pereira, Darren G Monckton
Nov 26, 2013·International Journal of Radiation Biology·Elena I SarapultsevaYuri E Dubrova
Dec 4, 2013·Dose-response : a Publication of International Hormesis Society·Elena I Sarapultseva, Anton I Gorski
Jun 12, 2016·Environmental Research·Elena I Sarapultseva, Yuri E Dubrova
Jan 4, 2017·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Friedo ZölzerRadim Šrám
Jan 1, 2012·Genes·Aurora Ruiz-HerreraMontserrat Garcia-Caldés
May 4, 2011·Environmental and Molecular Mutagenesis·Anna AghajanyanIgor Suskov
Jan 4, 2008·Environmental and Molecular Mutagenesis·Olga Kovalchuk, Janet E Baulch
Nov 8, 2019·Prenatal Diagnosis·Sandra A Lowe
May 8, 2020·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Veronika Lancíková, Jana Žiarovská
Dec 28, 2016·Bulletin of Environmental Contamination and Toxicology·J LemosA P Carvalho
Feb 14, 2007·Environmental and Molecular Mutagenesis·Andrew J WyrobekJack B Bishop
Dec 9, 2014·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·E Janet TawnPatricia Jonas
Oct 20, 2018·Scientific Reports·Jorke H KamstraPeter Aleström
Jun 5, 2021·Mutation Research. Reviews in Mutation Research· Swati, Vijayta D Chadha
Jun 5, 2021·Mutagenesis·Teena HaritwalPaban K Agrawala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.